Preserved Ejection Fraction and Risk Factors

Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study

Heart BMJ

MARCH 26, 2025

Background Heart failure with preserved ejection fraction is a recognised outcome in patients with myocardial infarction, although heart failure with reduced ejection fraction is more common. fold higher risk of heart failure with preserved ejection fraction (95% CI 1.30 m/s had a 2.10-fold

Aortic valve

Aortic valve Myocardial Infarction Preserved Ejection Fraction Heart Failure

Right ventricular function and anemia in heart failure with preserved ejection fraction

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

Multivariate linear regression analysis shows that the degree of anemia, atrial fibrillation, and TR were independently associated with the TAPSE/PASP ratio.ConclusionAnemia in HFpEF is associated with RV dysfunction, and this relationship is not affected by classical risk factors, such as smoking, hypertension, and diabetes.

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Tricuspid Atrial Fibrillation

Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction

Heart BMJ

MARCH 26, 2025

Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes.

Myocardial Infarction

Myocardial Infarction Preserved Ejection Fraction Heart Failure Aortic valve

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes

Cardiovascular Diabetology

OCTOBER 18, 2024

Type 2 diabetes mellitus (T2DM) is a major risk factor for heart failure with preserved ejection fraction and cardiac arrhythmias. Precursors of these complications, such as diabetic cardiomyopathy, remain inc.

Preserved Ejection Fraction

Preserved Ejection Fraction Diabetes Heart Failure Risk Factors

Hypertensive pregnancy disorder, an under‐recognized women specific risk factor for heart failure?

European Journal of Heart Failure

NOVEMBER 19, 2024

Hypertensive disorders of pregnancy as a risk factor for heart failure. Shortly after delivery, women who experienced HDP express increased risk of classic CV risk factors such as hypertension, renal disease, abnormal lipid profile, and diabetes.

Risk Factors

Risk Factors Heart Failure Hypertension Preserved Ejection Fraction

Abstract 4141446: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors Promote Resiliency to High Pressure Stress in the Human Microvasculature

Circulation

NOVEMBER 11, 2024

Emerging evidence suggests that vascular stress from cardiovascular-related co-morbidities promotes microvascular dysfunction, a key component in the development of heart failure with preserved ejection fraction.

Preserved Ejection Fraction

Preserved Ejection Fraction Arterioles Heart Failure Risk Factors

Correlation of ventricular pacing burden and left ventricular function in patients with heart failure with reduced ejection fraction

Journal of Cardiovascular Electrophysiology

DECEMBER 15, 2023

Impact of preceding systolic heart failure on risk of pacemaker-induced cardiomyopathy Abstract Background Pacemaker-induced cardiomyopathy is a well described phenomenon in patients with preserved ejection fraction at the time of permanent pacemaker implant.

Heart Failure

Heart Failure Preserved Ejection Fraction Pacemaker Cardiomyopathy

Metabolomic Association and Risk Prediction With Heart Failure in Older Adults

Circulation: Heart Failure

MARCH 1, 2024

BACKGROUND:Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF pathogenesis and improve at-risk population identification. Circulation: Heart Failure, Ahead of Print.

Heart Failure

Heart Failure Preserved Ejection Fraction Risk Factors Atherosclerosis

Proteomic prediction of incident heart failure and its main subtypes

European Journal of Heart Failure

NOVEMBER 8, 2023

Abstract Aim To examine the ability of serum proteins in predicting future heart failure (HF) events, including HF with reduced or preserved ejection fraction (HFrEF or HFpEF), in relation to event time, and with or without considering established HF-associated clinical variables.

Heart Failure

Heart Failure Preserved Ejection Fraction Article Risk Factors

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

Study Links E-Cigarette Use with Higher Risk of Heart Failure

DAIC

APRIL 2, 2024

In calculating this difference, researchers accounted for a variety of demographic and socioeconomic factors, other heart disease risk factors and participants’ past and current use of other substances, including alcohol and tobacco products.

Heart Failure

Heart Failure Preserved Ejection Fraction Research Risk Factors

Can heart failure phenotypes be predicted by cardiac remodelling peripartum or postpartum?

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

This review explores our current level of knowledge of the phenotypes of heart failure, paying particular attention to those specific to women, and the role of pregnancy and non-pregnancy related risk factors in the development of this condition.

Heart Failure

Heart Failure Preserved Ejection Fraction Coronary Artery Disease Hypertension

Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications

Journal of the American Heart Association

JANUARY 16, 2025

Patients with reduced left ventricular ejection fraction had higher PKM2 concentrations than those with preserved ejection fraction (18.34.5 A high PKM2 level had a 1.913fold higher risk of the primary outcome (P=0.033) after adjusting for multiple cardiovascular risk factors, but not with cardiovascular death.

Cardiac Function

Cardiac Function Heart Failure Biomarkers Preserved Ejection Fraction

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

JULY 25, 2023

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity

Obesity BMI Heart Failure Cardiovascular Disease

Metabolic dysfunction‐associated steatotic liver disease is associated with increased risks of heart failure

European Journal of Heart Failure

JANUARY 8, 2025

In this cohort study, metabolic dysfunction-associated steatotic liver disease (MASLD) was associated with a higher risk of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). There was a dose-dependent relationship between cardiometabolic risk factors and HF.

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Risk Factors Hospital

Hepatocyte growth factor and B-type natriuretic peptide as independent predictors of mortality in HFpEF patients

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

BackgroundHeart failure with preserved ejection fraction (HFpEF) is a common and heterogeneous syndrome with high mortality and morbidity. Multivariate logistic regression analysis was performed to identify the risk factors for all-cause mortality in HFpEF patients. The primary outcome was all-cause mortality.

Preserved Ejection Fraction

Preserved Ejection Fraction Risk Factors Biomarkers Hospital

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

NOVEMBER 14, 2024

42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S.,

CME

CME Obesity Heart Failure Biomarkers

Cardiovascular Update

Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study

Right ventricular function and anemia in heart failure with preserved ejection fraction

Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction

Webinars

Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes

Hypertensive pregnancy disorder, an under‐recognized women specific risk factor for heart failure?

Abstract 4141446: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors Promote Resiliency to High Pressure Stress in the Human Microvasculature

Correlation of ventricular pacing burden and left ventricular function in patients with heart failure with reduced ejection fraction

Metabolomic Association and Risk Prediction With Heart Failure in Older Adults

Proteomic prediction of incident heart failure and its main subtypes

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

Study Links E-Cigarette Use with Higher Risk of Heart Failure

Can heart failure phenotypes be predicted by cardiac remodelling peripartum or postpartum?

Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Metabolic dysfunction‐associated steatotic liver disease is associated with increased risks of heart failure

Hepatocyte growth factor and B-type natriuretic peptide as independent predictors of mortality in HFpEF patients

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Stay Connected